Evidence map›Paper›PMID 42076323›Full record

ReviewPolymers2026

Extracting Caprolactam from PA6 Waste: Progress in Chemical Recycling and Sustainable Practices.

Damayanti Damayanti, Mega Pristiani, Ho-Shing Wu

Abstract readReview
In one paragraph

Review in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Damayanti DamayantiDepartment of Chemical Engineering and Materials Science, Yuan Ze University, 135 Yuan-Tung Road, Chung-Li, Taoyuan 320315, Taiwan.ORCID 0000-0001-9675-1033
Mega PristianiDepartment of Chemical Engineering and Materials Science, Yuan Ze University, 135 Yuan-Tung Road, Chung-Li, Taoyuan 320315, Taiwan.
Ho-Shing WuDepartment of Chemical Engineering and Materials Science, Yuan Ze University, 135 Yuan-Tung Road, Chung-Li, Taoyuan 320315, Taiwan.ORCID 0000-0001-7153-8105

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review critically evaluates current PA6 recycling technologies, with a specific focus on caprolactam-oriented chemical recycling pathways, including hydrolysis, pyrolysis, glycolysis, ammonolysis, hydrothermal treatment, ionic-liquid-assisted depolymerization, and microwave-assisted processes. Reported caprolactam yields vary significantly depending on reaction conditions and catalyst systems, ranging from below 60 wt% in conventional hydrolysis to above 90 wt% under optimized catalytic, hydrothermal, or microwave-assisted conditions. Among these approaches, microwave-assisted hydrolysis and catalytic depolymerization have emerged as particularly promising, offering substantially reduced reaction times (minutes rather than hours), improved energy efficiency, and high monomer selectivity at moderate temperatures (typically 200-350 °C). This review integrates kinetic modeling approaches, analytical methods for monitoring depolymerization, and downstream separation considerations that govern monomer purity and recyclability. Key challenges, including energy demand, feedstock contamination, scalability, and economic competitiveness, are critically discussed in relation to industrial implementation. Overall, hydrolysis-based and microwave-assisted chemical recycling routes are the most viable pathways for closed-loop recycling of PA6. Future progress will rely on integrated reaction-separation-repolymerization designs, catalyst optimization, and process intensification to enable sustainable and industrially relevant PA6 circularity.

Indexed as

caprolactamchemical recyclingmechanical recyclingnylonpolyamide 6polycaprolactamsustainability

Identifiers

PMID42076323
PMCPMC13120444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.